Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Photochemical CO2 reduction with mononuclear and dinuclear rhenium catalysts bearing a pendant anthracene chromophore.

Liyanage NP, Yang W, Guertin S, Sinha Roy S, Carpenter CA, Adams RE, Schmehl RH, Delcamp JH, Jurss JW.

Chem Commun (Camb). 2019 Jan 17;55(7):993-996. doi: 10.1039/c8cc09155b.

PMID:
30608072
2.

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition.

Vaccari M, Fourati S, Gordon SN, Brown DR, Bissa M, Schifanella L, Silva de Castro I, Doster MN, Galli V, Omsland M, Fujikawa D, Gorini G, Liyanage NPM, Trinh HV, McKinnon KM, Foulds KE, Keele BF, Roederer M, Koup RA, Shen X, Tomaras GD, Wong MP, Munoz KJ, Gach JS, Forthal DN, Montefiori DC, Venzon DJ, Felber BK, Rosati M, Pavlakis GN, Rao M, Sekaly RP, Franchini G.

Nat Med. 2018 Jun;24(6):847-856. doi: 10.1038/s41591-018-0025-7. Epub 2018 May 21.

3.

Nickel(ii) pincer complexes demonstrate that the remote substituent controls catalytic carbon dioxide reduction.

Burks DB, Davis S, Lamb RW, Liu X, Rodrigues RR, Liyanage NP, Sun Y, Webster CE, Delcamp JH, Papish ET.

Chem Commun (Camb). 2018 Apr 12;54(31):3819-3822. doi: 10.1039/C7CC09507D.

PMID:
29560991
4.

Ruthenium(ii) complexes of pyridinol and N-heterocyclic carbene derived pincers as robust catalysts for selective carbon dioxide reduction.

Boudreaux CM, Liyanage NP, Shirley H, Siek S, Gerlach DL, Qu F, Delcamp JH, Papish ET.

Chem Commun (Camb). 2017 Oct 18;53(81):11217-11220. doi: 10.1039/c7cc05706g. Epub 2017 Sep 28.

PMID:
28956560
5.

Electrocatalytic reduction of CO2 with CCC-NHC pincer nickel complexes.

Cope JD, Liyanage NP, Kelley PJ, Denny JA, Valente EJ, Webster CE, Delcamp JH, Hollis TK.

Chem Commun (Camb). 2017 Aug 22;53(68):9442-9445. doi: 10.1039/c6cc06537f.

PMID:
28792548
6.

Stool antigen immunodetection for diagnosis of Giardia duodenalis infection in human subjects with HIV and cancer.

Nooshadokht M, Kalantari-Khandani B, Sharifi I, Kamyabi H, Liyanage NPM, Lagenaur LA, Kagnoff MF, Singer SM, Babaei Z, Solaymani-Mohammadi S.

J Microbiol Methods. 2017 Oct;141:35-41. doi: 10.1016/j.mimet.2017.07.004. Epub 2017 Jul 14.

7.

Effect of Donor Strength and Bulk on Thieno[3,4-b]-pyrazine-Based Panchromatic Dyes in Dye-Sensitized Solar Cells.

Liyanage NP, Cheema H, Baumann AR, Zylstra AR, Delcamp JH.

ChemSusChem. 2017 Jun 22;10(12):2635-2641. doi: 10.1002/cssc.201700546. Epub 2017 May 19.

PMID:
28444717
8.

Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, Liang F, Loré K, Roederer M, Koup RA, McDermott A, Ma ZM, Miller CJ, Phan TB, Forthal DN, Blackburn M, Caccuri F, Bissa M, Ferrari G, Kalyanaraman V, Ferrari MG, Thompson D, Robert-Guroff M, Ratto-Kim S, Kim JH, Michael NL, Phogat S, Barnett SW, Tartaglia J, Venzon D, Stablein DM, Alter G, Sekaly RP, Franchini G.

Nat Med. 2016 Oct 6;22(10):1192. doi: 10.1038/nm1016-1192a. No abstract available.

PMID:
27711066
9.

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition.

Gordon SN, Liyanage NP, Doster MN, Vaccari M, Vargas-Inchaustegui DA, Pegu P, Schifanella L, Shen X, Tomaras GD, Rao M, Billings EA, Schwartz J, Prado I, Bobb K, Zhang W, Montefiori DC, Foulds KE, Ferrari G, Robert-Guroff M, Roederer M, Phan TB, Forthal DN, Stablein DM, Phogat S, Venzon DJ, Fouts T, Franchini G.

J Immunol. 2016 Oct 1;197(7):2726-37. doi: 10.4049/jimmunol.1600674. Epub 2016 Sep 2.

10.

Electrocatalytic Reduction of CO2 to CO With Re-Pyridyl-NHCs: Proton Source Influence on Rates and Product Selectivities.

Liyanage NP, Dulaney HA, Huckaba AJ, Jurss JW, Delcamp JH.

Inorg Chem. 2016 Jun 20;55(12):6085-94. doi: 10.1021/acs.inorgchem.6b00626. Epub 2016 Jun 9.

PMID:
27281546
11.

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, Liang F, Loré K, Roederer M, Koup RA, McDermott A, Ma ZM, Miller CJ, Phan TB, Forthal DN, Blackburn M, Caccuri F, Bissa M, Ferrari G, Kalyanaraman V, Ferrari MG, Thompson D, Robert-Guroff M, Ratto-Kim S, Kim JH, Michael NL, Phogat S, Barnett SW, Tartaglia J, Venzon D, Stablein DM, Alter G, Sekaly RP, Franchini G.

Nat Med. 2016 Jul;22(7):762-70. doi: 10.1038/nm.4105. Epub 2016 May 30. Erratum in: Nat Med. 2016 Oct 6;22(10 ):1192.

12.

Thieno[3,4-b]pyrazine as an Electron Deficient π-Bridge in D-A-π-A DSCs.

Liyanage NP, Yella A, Nazeeruddin M, Grätzel M, Delcamp JH.

ACS Appl Mater Interfaces. 2016 Mar 2;8(8):5376-84. doi: 10.1021/acsami.5b12503. Epub 2016 Feb 19.

PMID:
26866909
13.

Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.

Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M Jr, Lifson JD, Xenophontos AM, Venzon D, Robert-Guroff M, Graham BS, Lowy DR, Schiller JT, Franchini G.

J Immunol. 2014 Dec 15;193(12):6172-83. doi: 10.4049/jimmunol.1401504. Epub 2014 Nov 14.

14.

Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.

Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington GR, Bear J, Alicea C, Vargas-Inchaustegui DA, Jean Patterson L, Pegu P, Liyanage NP, Gordon SN, Vaccari M, Wang Y, Hogg AE, Frey B, Sui Y, Reed SG, Sardesai NY, Berzofsky JA, Franchini G, Robert-Guroff M, Felber BK, Pavlakis GN.

Clin Immunol. 2014 Nov;155(1):91-107. doi: 10.1016/j.clim.2014.09.005. Epub 2014 Sep 16.

15.

Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.

Vargas-Inchaustegui DA, Tuero I, Mohanram V, Musich T, Pegu P, Valentin A, Sui Y, Rosati M, Bear J, Venzon DJ, Kulkarni V, Alicea C, Pilkington GR, Liyanage NP, Demberg T, Gordon SN, Wang Y, Hogg AE, Frey B, Patterson LJ, DiPasquale J, Montefiori DC, Sardesai NY, Reed SG, Berzofsky JA, Franchini G, Felber BK, Pavlakis GN, Robert-Guroff M.

Clin Immunol. 2014 Aug;153(2):308-22. doi: 10.1016/j.clim.2014.05.008. Epub 2014 Jun 4.

16.

Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

Liyanage NP, Gordon SN, Doster MN, Pegu P, Vaccari M, Shukur N, Schifanella L, Pise-Masison CA, Lipinska D, Grubczak K, Moniuszko M, Franchini G.

Virology. 2014 Feb;450-451:359-68. doi: 10.1016/j.virol.2013.12.003. Epub 2014 Jan 21.

17.

Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.

Moniuszko M, Liyanage NP, Doster MN, Parks RW, Grubczak K, Lipinska D, McKinnon K, Brown C, Hirsch V, Vaccari M, Gordon S, Pegu P, Fenizia C, Flisiak R, Grzeszczuk A, Dabrowska M, Robert-Guroff M, Silvestri G, Stevenson M, McCune J, Franchini G.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):115-26. doi: 10.1089/AID.2013.0220.

18.

Contribution of Helicobacter hepaticus cytolethal distending toxin subunits to human epithelial cell cycle arrest and apoptotic death in vitro.

Liyanage NP, Dassanayake RP, Kuszynski CA, Duhamel GE.

Helicobacter. 2013 Dec;18(6):433-43. doi: 10.1111/hel.12084. Epub 2013 Jul 29.

19.

Glucocorticoids upregulate decreased IL-7 receptor expression in asthmatic patients and simian immunodeficiency virus-infected non-human primates.

Moniuszko M, Lipinska D, Jeznach M, Kowal K, Grubczak K, Rusak M, McKinnon K, Vaccari M, Liyanage NP, Fenizia C, Wawrusiewicz-Kurylonek N, Dabrowska M, Jablonska E, Kretowski A, Gorska M, Bodzenta-Lukaszyk A.

J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):427-42.

PMID:
23830393
20.

Helicobacter hepaticus cytolethal distending toxin causes cell death in intestinal epithelial cells via mitochondrial apoptotic pathway.

Liyanage NP, Manthey KC, Dassanayake RP, Kuszynski CA, Oakley GG, Duhamel GE.

Helicobacter. 2010 Apr;15(2):98-107. doi: 10.1111/j.1523-5378.2010.00749.x.

PMID:
20402812
21.

Regulation of the bioavailability of thioredoxin in the lens by a specific thioredoxin-binding protein (TBP-2).

Liyanage NP, Fernando MR, Lou MF.

Exp Eye Res. 2007 Aug;85(2):270-9. Epub 2007 May 21.

22.

Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka.

Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT, Vitarana T.

Indian J Med Sci. 2007 Mar;61(3):128-34.

PMID:
17337813

Supplemental Content

Loading ...
Support Center